Houston, Texas October 6, 2009 – London American Risk Specialists, Inc. is pleased to congratulate our mutual Chapman & Associates client, Global Solutions for Infectious Diseases (GSID) for its work in the development of a new HIV preventative vaccine. According to newspaper articles published by the Los Angeles Times and Dallas Morning News, GSID recently announced that their clinical trials of this HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection and may certainly lead to the next generation of vaccines for AIDS.
Global Solutions for Infectious Diseases, a non-profit organization, is dedicated to changing the world through the development of low-cost effective solutions for the prevention of infectious diseases such as AIDS.
For more information concerning this topic please feel free to contact Mike Mullens at London American Risk Specialists, Dallas, Texas. 214-373-3936 (ext 206) or email mmullens@londonamericantx.com
Again, our heartfelt congratulations to Global Solutions for Infections Diseases for their tireless efforts to help make the world a healthier place.
Banks Still Face Legal Claims After $25 Billion Settlement
MF Global Judge to Examine Insurance Payments for Former Executives
Daredevil CEOs May Put Companies at Risk
California Independent Contractor Law May Be Liability for Agents, Brokers
North Carolina Continues Auto Regulation Debate As Rates Stay Same for 2012
Long-time California Lobbyist Looks to 2012 Legislation Affecting Insurance
Mine Safety Chief Seeks to End Complacency Over Safety
Virginia Court Grants Rehearing of Global Warming Claims Case
